Found: 158
Select item for more details and to access through your institution.
Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 10, p. 2813, doi. 10.1007/s00520-014-2268-2
- By:
- Publication type:
- Article
Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Erratum to: Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1011, doi. 10.3390/cells12071011
- By:
- Publication type:
- Article
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1104124
- By:
- Publication type:
- Article
CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.931316
- By:
- Publication type:
- Article
The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.938063
- By:
- Publication type:
- Article
Giant Borderline Phyllodes Tumor of the Breast.
- Published in:
- Breast Journal, 2008, v. 14, n. 2, p. 203, doi. 10.1111/j.1524-4741.2007.00558.x
- By:
- Publication type:
- Article
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e426, doi. 10.1093/cid/ciac404
- By:
- Publication type:
- Article
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.
- Published in:
- Molecules, 2022, v. 27, n. 11, p. 3545, doi. 10.3390/molecules27113545
- By:
- Publication type:
- Article
Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?
- Published in:
- Molecules, 2021, v. 26, n. 22, p. 6877, doi. 10.3390/molecules26226877
- By:
- Publication type:
- Article
From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy.
- Published in:
- Molecules, 2021, v. 26, n. 8, p. 2278, doi. 10.3390/molecules26082278
- By:
- Publication type:
- Article
Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines.
- Published in:
- Molecules, 2021, v. 26, n. 4, p. 901, doi. 10.3390/molecules26040901
- By:
- Publication type:
- Article
Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma.
- Published in:
- Molecules, 2020, v. 25, n. 21, p. 5148, doi. 10.3390/molecules25215148
- By:
- Publication type:
- Article
Challenges and Opportunities of MicroRNAs in Lymphomas.
- Published in:
- Molecules, 2014, v. 19, n. 9, p. 14723, doi. 10.3390/molecules190914723
- By:
- Publication type:
- Article
The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment.
- Published in:
- Molecules, 2014, v. 19, n. 5, p. 6393, doi. 10.3390/molecules19056393
- By:
- Publication type:
- Article
Role of MicroRNA in Response to Ionizing Radiations: Evidences and Potential Impact on Clinical Practice for Radiotherapy.
- Published in:
- Molecules, 2014, v. 19, n. 4, p. 5379, doi. 10.3390/molecules19045379
- By:
- Publication type:
- Article
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract.
- Published in:
- Molecules, 2014, v. 19, n. 2, p. 2458, doi. 10.3390/molecules19022458
- By:
- Publication type:
- Article
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 532, doi. 10.3390/vaccines9050532
- By:
- Publication type:
- Article
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40637-z
- By:
- Publication type:
- Article
Actors on the Scene: Immune Cells in the Myeloma Niche.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.599098
- By:
- Publication type:
- Article
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572329
- By:
- Publication type:
- Article
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01587
- By:
- Publication type:
- Article
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01292
- By:
- Publication type:
- Article
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.01340
- By:
- Publication type:
- Article
Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0766-7
- By:
- Publication type:
- Article
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0598-x
- By:
- Publication type:
- Article
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12795, doi. 10.3390/ijms241612795
- By:
- Publication type:
- Article
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10719, doi. 10.3390/ijms221910719
- By:
- Publication type:
- Article
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10389, doi. 10.3390/ijms221910389
- By:
- Publication type:
- Article
The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2652, doi. 10.3390/ijms22052652
- By:
- Publication type:
- Article
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8305, doi. 10.3390/ijms21218305
- By:
- Publication type:
- Article
Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6545, doi. 10.3390/ijms21186545
- By:
- Publication type:
- Article
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 5034, doi. 10.3390/ijms21145034
- By:
- Publication type:
- Article
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4427, doi. 10.3390/ijms21124427
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3054, doi. 10.3390/ijms21093054
- By:
- Publication type:
- Article
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2578, doi. 10.3390/ijms21072578
- By:
- Publication type:
- Article
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 418, doi. 10.3390/ijms18020418
- By:
- Publication type:
- Article
Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 10, p. 19731, doi. 10.3390/ijms141019731
- By:
- Publication type:
- Article
Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1389, doi. 10.1111/liv.14817
- By:
- Publication type:
- Article
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 704, doi. 10.1111/liv.14314
- By:
- Publication type:
- Article
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
- Published in:
- Genes, 2021, v. 12, n. 8, p. 1206, doi. 10.3390/genes12081206
- By:
- Publication type:
- Article
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.
- Published in:
- Genes, 2021, v. 12, n. 2, p. 267, doi. 10.3390/genes12020267
- By:
- Publication type:
- Article
Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295863
- By:
- Publication type:
- Article
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4232, doi. 10.3390/ijms25084232
- By:
- Publication type:
- Article
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 481, n. 1, p. 41, doi. 10.1007/s00428-022-03317-4
- By:
- Publication type:
- Article
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 6, p. 1261, doi. 10.1007/s00428-021-03205-3
- By:
- Publication type:
- Article
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 783, doi. 10.1007/s10120-022-01292-y
- By:
- Publication type:
- Article